Literature DB >> 7954363

Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis.

V Elangovan1, N Sekar, S Govindasamy.   

Abstract

The effect of dietary supplementation of flavonoidal compounds such as quercetin, rutin, luteolin and (+)-catechin on the incidence of fibrosarcoma induced by 20-methylcholanthrene (20-MC) in male Swiss albino mice was observed. Subcutaneous injection of 20-MC produced 100% tumor incidence and the onset of tumor appeared within 7 weeks, while flavonoid-treated mice (1% quercetin- and luteolin-mixed diets) produced tumors in the 9th week, and the tumor incidences in mice treated with quercetin- and luteolin-mixed diets were 52% and 60%, respectively. Subcutaneous administration of 20-MC along with the flavonoidal compounds (quercetin, luteolin) was found to have significant effect on tumor expression. The compounds rutin and (+)-catechin did not influence tumor expression in both experiments. Elevated levels of lipid peroxides, cytochrome P450 and decreased activity of glutathione-S-transferase (GST) were observed in the tumor bearing animals. Test-diet-treated animals showed reduction in the lipid peroxides and cytochrome P450, and increased activity of GST (P < 0.001). In vitro [3H]thymidine incorporation showed the inhibition of DNA synthesis in fibrosarcoma cells by the flavonoids. The possible mode of action of the flavonoidal compounds may be through their influence on the initiation and promotion phases of the carcinogenic process coupled with enhancement of the detoxification process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954363     DOI: 10.1016/0304-3835(94)90416-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Potent antioxidant dendrimers lacking pro-oxidant activity.

Authors:  Choon Young Lee; Ajit Sharma; Rebecca L Uzarski; Jae Eun Cheong; Hao Xu; Rich A Held; Samik K Upadhaya; Julie L Nelson
Journal:  Free Radic Biol Med       Date:  2010-10-23       Impact factor: 7.376

2.  Anti-inflammatory and antioxidant properties of Eriobotrya japonica leaves extracts.

Authors:  Kammoun Maher; Ben Ali Yassine; Bezzine Sofiane
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

3.  "Combination-oriented molecular-targeting prevention" of cancer: a model involving the combination of TRAIL and a DR5 inducer.

Authors:  Tatsushi Yoshida; Mano Horinaka; Toshiyuki Sakai
Journal:  Environ Health Prev Med       Date:  2010-01-06       Impact factor: 3.674

Review 4.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

5.  Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.

Authors:  Thilakavathy Thangasamy; Sivanandane Sittadjody; Geoffrey C Mitchell; Erin E Mendoza; Vijayababu M Radhakrishnan; Kirsten H Limesand; Randy Burd
Journal:  BMC Cancer       Date:  2010-06-11       Impact factor: 4.430

6.  Quantitative structure-antioxidant activity relationships of flavonoid compounds.

Authors:  Orsolya Farkas; Judit Jakus; Károly Héberger
Journal:  Molecules       Date:  2004-12-31       Impact factor: 4.411

7.  Synthesis and antioxidant properties of dendritic polyphenols.

Authors:  Choon Young Lee; Ajit Sharma; Jae Eun Cheong; Julie L Nelson
Journal:  Bioorg Med Chem Lett       Date:  2009-09-25       Impact factor: 2.823

8.  Antioxidant and antinociceptive effects of Citrus limon essential oil in mice.

Authors:  Lidianne Mayra Lopes Campêlo; Antonia Amanda C de Almeida; Rizângela L Mendes de Freitas; Gilberto Santos Cerqueira; Geane Felix de Sousa; Gláucio Barros Saldanha; Chistiane Mendes Feitosa; Rivelilson Mendes de Freitas
Journal:  J Biomed Biotechnol       Date:  2011-05-31

9.  Peanut skin color: a biomarker for total polyphenolic content and antioxidative capacities of peanut cultivars.

Authors:  Yvonne Chukwumah; Lloyd T Walker; Martha Verghese
Journal:  Int J Mol Sci       Date:  2009-11-11       Impact factor: 6.208

10.  The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study.

Authors:  A M E Bruynzeel; H W M Niessen; J G F Bronzwaer; J J M van der Hoeven; J Berkhof; A Bast; W J F van der Vijgh; C J van Groeningen
Journal:  Br J Cancer       Date:  2007-10-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.